Drug combination reduces colon cancer risk (Reuters)
Reuters - Combining a low dose of a targeted
cancer-fighter with an anti-inflammatory drug reduces the risk
of recurring colorectal polyps, an early sign of colon cancer,
by as much as 95 percent, researchers said on Monday.
Oryginal: Reuters
Posted: April 14th, 2008 under NEWS.
Comments: none
Related articles
- Antipsychotics Dangerous for Elderly With Dementia (HealthDay) (May 27th, 2008)
- Health Tip: Get Your Child Back to Bed (HealthDay) (May 27th, 2008)
- Gum Disease Might Boost Cancer Risk (HealthDay) (May 27th, 2008)
- Researchers studying better insect repellants (AP) (May 27th, 2008)
- ADHD can cost adults 20 or more workdays a year (AP) (May 27th, 2008)